The recent carbapenem-resistant Enterobacteriaceae (CRE) outbreaks have left many hospitals wondering what to do to make sure patients are safe and still have access to important medical devices, according to an article on the Fierce Healthcare website.
The Food and Drug Administration (FDA) said the complex design of duodenoscopes makes them difficult to sterilize even when hospitals follow the device manufacturers' instructions. However, the FDA has refused to take the devices off the market because they are used for potentially life-saving procedures.
Jackie Caynon, a partner and co-chair of Mirick O'Connell's Health Law Group, said the answer has to come from each hospital's unique risk management assessment.
"I've heard some hospitals say, you know these things are really life-saving, so if we get rid of the product we won't be able to, obviously, save lives," he said. But for others, he said, the risk may be too great.
Mattresses Require Strict Care to Prevent Spread of Infections
Gardner Health Services Opens Alum Rock Health Center
The Children's Center of Hamden Reports Data Security Incident
Designing for Senior Care Communities Means Designing for Everyone
Harlem Hospital Legionnaires' Outbreak Highlights Cooling Tower Risks